Breast target dimensions correlate with lung and heart dose in right-sided VMAT

In 33 right-sided breast RT patients, larger target dimensions correlated with higher ipsilateral lung and cardiac doses, but proposed thresholds remain unvalidated.

KEY POINTS

  • This retrospective single-center study from Chongqing, China, evaluated 33 women receiving postoperative radiotherapy after breast-conserving surgery for right-sided T1–2N0–1 breast cancer. All patients received VMAT delivering 43.5 Gy in 15 fractions to the whole breast, with a simultaneous integrated boost to 49.5 Gy in 15 fractions. Investigators measured three target-geometry parameters on the nipple-center CT slice: transverse diameter (TD), oblique diameter (OD), and the TD-to-OD ratio (TOR).
  • Target geometry showed moderate-to-strong correlations with ipsilateral lung dose. Both transverse and oblique dimensions correlated with lung V20Gy, V5Gy and mean dose, with reported Pearson coefficients in the approximate range 0.5–0.7 (p<0.01). Mean ipsilateral lung V20Gy was 14.77 ± 3.48%, V5Gy was 31.39 ± 4.99%, and mean dose was 8.12 ± 1.46 Gy. These associations were evaluated within one standardized VMAT planning workflow.
  • Transverse target dimension was also associated with cardiac exposure despite right-sided treatment. TD correlated with mean heart dose (R=0.58; p<0.01), mean right coronary artery dose (R=0.45; p<0.01) and mean LAD dose (R=0.42; p<0.05). TOR also correlated with mean heart dose and mean LAD dose (R=0.47 for both). Mean delivered planning doses were relatively low: 1.46 Gy for the heart, 2.67 Gy for the right coronary artery, and 1.55 Gy for the LAD.
  • The proposed anatomical warning thresholds were exploratory and not validated. The authors suggested TD >8.00 cm or OD >19.56 cm as possible indicators of elevated lung exposure, and TD >8.00 cm or TOR >0.47 as indicators of higher cardiac dose. However, these values were derived from fitted relationships within the same small cohort rather than ROC-based threshold optimization, and several lie at or beyond the upper range of the reported anatomical measurements.
  • The TD-to-OD ratio did not significantly correlate with all lung-dose parameters, despite its associations with selected cardiac endpoints. The study also found no convincing relationship between the investigated target dimensions and contralateral breast dose. This suggests that simple geometric measurements capture only part of the variation in dose distribution, with beam arrangement, patient anatomy, optimization objectives and other factors also influencing OAR exposure.
  • The investigators applied Benjamini–Hochberg false-discovery-rate correction to address the multiple correlation tests, but the small sample and interdependence of dose metrics still limit interpretation. All measurements were performed by one medical physicist, and interobserver reproducibility was not assessed. The study included no alternative beam arrangement, photon technique comparison, deep-inspiration breath-hold intervention, or model validation against independent patients.
  • No clinical toxicity outcomes were evaluated. Associations between target dimensions and planned dose cannot establish differences in pneumonitis, ischemic cardiac events, or other late complications. The proposed thresholds should therefore not be used for patient-level risk stratification or as replacements for direct evaluation of heart, coronary and lung DVHs.

CLINICAL TAKEAWAY

Simple target-geometry measurements may help explain variation in lung and heart exposure during right-sided breast VMAT planning, but the observed correlations provide limited information beyond direct dosimetric assessment. The small cohort and unvalidated anatomical thresholds mean that these findings should be considered exploratory and are insufficient to guide clinical planning decisions independently.

SOURCE

Frontiers in Oncology

Browse more research Suggest a correction